Abdominal (visceral) adiposity increases with the onset of menopause.
Abdominal tissue redistribution with menopause appears to be independent of age and total body fat and could be related to a relative deficit in estrogens.
Menopause has a negative impact on plasma lipoprotein-lipid levels, which may increase CVD risk.
HTR in post-menopausal women helps protect against intra-abdominal fat accumulation. However, prospective studies that have assessed “hard” CVD endpoints have failed to confirm HRT’s benefits. Current evidence does not support the use of HRT to reduce menopause-related CVD risk.
Evaluation of the association between the first observation and the longitudinal change in C-reactive protein, and all-cause mortality. Heart 2008;94:457-62